Aurora(ACB) ZACKS·2025-02-05 14:51Earnings Performance - Aurora Cannabis reported quarterly earnings of 0 04 per share, representing a 50% earnings surprise [1] - The company posted revenues of 53 34 million [2] - Over the last four quarters, the company has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Performance and Market Comparison - Aurora Cannabis shares have lost about 13 4% since the beginning of the year, underperforming the S&P 500's gain of 2 7% [3] - The stock's immediate price movement will depend on management's commentary on the earnings call [3] Earnings Outlook and Estimate Revisions - The current consensus EPS estimate is 59 38 million in revenues for the coming quarter and -220 99 million in revenues for the current fiscal year [7] - The estimate revisions trend for Aurora Cannabis is mixed, translating into a Zacks Rank 3 (Hold), indicating the shares are expected to perform in line with the market in the near future [6] Industry Context - Aurora Cannabis belongs to the Zacks Medical - Products industry, which is currently in the bottom 46% of the 250 plus Zacks industries [8] - The top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [8] Peer Comparison - Curaleaf Holdings, Inc (CURLF), another stock in the same industry, is expected to post a quarterly loss of 331 87 million, down 3 9% from the year-ago quarter [10]